title: MitoCeption: Transferring Isolated Human MSC Mitochondria to Glioblastoma Stem Cells.
abstract: Mitochondria play a central role for cell metabolism, energy production and control of apoptosis. Inadequate mitochondrial function has been found responsible for very diverse diseases, ranging from neurological pathologies to cancer. Interestingly, mitochondria have recently been shown to display the capacity to be transferred between cell types, notably from human mesenchymal stem cells (MSC) to cancer cells in coculture conditions, with metabolic and functional consequences for the mitochondria recipient cells, further enhancing the current interest for the biological properties of these organelles. Evaluating the effects of the transferred MSC mitochondria in the target cells is of primary importance to understand the biological outcome of such cell-cell interactions. The MitoCeption protocol described here allows the transfer of the mitochondria isolated beforehand from the donor cells to the target cells, using MSC mitochondria and glioblastoma stem cells (GSC) as a model system. This protocol has previously been used to transfer mitochondria, isolated from MSCs, to adherent MDA-MB-231 cancer cells. This mitochondria transfer protocol is adapted here for GSCs that present the specific particularity of growing as neurospheres in vitro. The transfer of the isolated mitochondria can be followed by fluorescence-activated cell sorting (FACS) and confocal imaging using mitochondria vital dyes. The use of mitochondria donor and target cells with distinct haplotypes (SNPs) also allows detection of the transferred mitochondria based on the concentration of their circular mitochondrial DNA (mtDNA) in the target cells. Once the protocol has been validated with these criteria, the cells harboring the transferred mitochondria can be further analyzed to determine the effects of the exogenous mitochondria on biological properties such as cell metabolism, plasticity, proliferation and response to therapy.
authors.affiliation: Institute for Regenerative Medicine and Biotherapy (IRMB), INSERM U1183, Montpellier University.
authors.forename: Brice
authors.initials: B
authors.lastname: Nzigou Mombo
authors.affiliation: Institute for Regenerative Medicine and Biotherapy (IRMB), INSERM U1183, Montpellier University.
authors.forename: Sabine
authors.initials: S
authors.lastname: Gerbal-Chaloin
authors.affiliation: Institute for Regenerative Medicine and Biotherapy (IRMB), INSERM U1183, Montpellier University.
authors.forename: Aleksandra
authors.initials: A
authors.lastname: Bokus
authors.affiliation: Institute for Regenerative Medicine and Biotherapy (IRMB), INSERM U1183, Montpellier University.
authors.forename: Martine
authors.initials: M
authors.lastname: Daujat-Chavanieu
authors.affiliation: Institute for Regenerative Medicine and Biotherapy (IRMB), INSERM U1183, Montpellier University.
authors.forename: Christian
authors.initials: C
authors.lastname: Jorgensen
authors.affiliation: Institute of Neurosciences of Montpellier (INM), INSERM U1051, Montpellier University.
authors.forename: Jean-Philippe
authors.initials: JP
authors.lastname: Hugnot
authors.affiliation: Institute for Regenerative Medicine and Biotherapy (IRMB), INSERM U1183, Montpellier University; marie-luce.vignais@inserm.fr.
authors.forename: Marie-Luce
authors.initials: ML
authors.lastname: Vignais
mesh_terms: D017209:Apoptosis; D001932:Brain Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D002450:Cell Communication; D045744:Cell Line, Tumor; D004272:DNA, Mitochondrial / Q000378:metabolism*; D005434:Flow Cytometry; D005909:Glioblastoma / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D006801:Humans; D059630:Mesenchymal Stem Cells / Q000378:metabolism* / Q000473:pathology; D018613:Microscopy, Confocal; D008928:Mitochondria / Q000235:genetics / Q000378:metabolism*
chemical_list: D004272:DNA, Mitochondrial